0.8080EUR-3.81%Mkt Cap: 244.38M $P/E: —Today
Transgene SA, a biotechnology company, designs and develops therapeutic vaccines and oncolytic viruses for the treatment of cancer in France. It involved in developing TG4050, a therapeutic vaccine that is in Phase II cl…
Industry Peers
Biotechnology$130.23BUSDP/E 32.1
$139.84BUSDP/E 32.2
$85.11BUSDP/E 20.4
$69.62BUSD
$61.34BUSDP/E 39.8
$45.95BUSDP/E 19.6
$46.01BUSD
$41.76BUSDP/E 66.2
$35.67BUSDP/E 33.2
$32.46BUSDP/E 42.3
$28.53BUSD
$26.14BUSD
$25.79BUSDP/E 16.2
$20.83BUSDP/E 26.3
$19.26BUSDP/E 26.6
$17.03BUSDP/E 20.0
$16.41BUSD
$13.48BUSDP/E 17.1
$13.42BUSDP/E 187.4
$12.87BUSDP/E 264.5
Key Statistics
Company
Market Cap244.38M $
Enterprise Value130.12M $
Revenue (TTM)7.84M $
Gross Profit-29.01M $
Net Income (TTM)-40.79M $
Revenue/Share0.0543 USD
Last Price0.8080 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees145
CountryFR
SectorHealthcare
IndustryBiotechnology
ISINFR0005175080
Valuation
P/E (Trailing)—
P/E (Forward)-3.81
PEG3.08
EV/EBITDA-3.55
EV/Revenue16.60
P/S32.34
P/B1.89
EPS (TTM)-0.26
EPS (Forward)-0.22
52W Range
0.705013% of range1.500
52W High1.500 EUR
52W Low0.7050 EUR
Profitability
Gross Margin0.00%
Oper. Margin-684.11%
EBITDA Margin0.00%
Profit Margin-7657.96%
ROE-30.82%
ROA-27.03%
Growth
Revenue Growth-12.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-40.27M $
CapEx (TTM)915.22K $
FCF Margin-348.38%
FCF Yield-11.17%
Net Debt-119.35M $
Net Debt/EBITDA3.25
Balance Sheet
Debt/Equity0.00
Current Ratio9.62
Quick Ratio9.55
Book Value/Sh0.4440 EUR
Cash/Share0.4080 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)1.100 EUR
Upside (mean)+36.1%
Target Range1.100 EUR – 1.100 EUR
# Analysts1
Ownership
Shares Out.278.26M
Float48.87M
Insiders80.78%
Institutions0.00%
Technical
SMA 500.7363 (+9.7%)
SMA 2000.8460 (-4.5%)
Beta0.68
S&P 52W Chg18.16%
Avg Vol (30d)69.61K
Avg Vol (10d)114.38K
Technical Indicators
RSI (14)79.6
MACD0.0133
MACD Signal-0.0017
MACD Hist.+0.0150
BB Upper0.8090 EUR
BB Middle0.7290 EUR
BB Lower0.6491 EUR
BB Width21.94%
ATR (14)0.0203 EUR
Vol Ratio (20d)3.72x